Skip to main content
Clinical Trials/NCT05342363
NCT05342363
Completed
Not Applicable

Mechanical Cardiopulmonary Resuscitation During Treatment of Acute Respiratory Failure Through Extracorporeal Membrane Oxygenation.

Goethe University1 site in 1 country117 target enrollmentJune 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Resuscitation
Sponsor
Goethe University
Enrollment
117
Locations
1
Primary Endpoint
Survival of mechanical cardiovascular resuscitation
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

In-hospital cardiovascular arrest is associated with poor outcome despite prompt treatment and optimal on-site resources. The population of patients treated by venovenous extracorporeal membrane oxygenation (vv-ECMO) due to pulmonary failure is a very challenging group of patients. To date, the frequency, causes and outcome of cardiovascular arrest in these patients have not been studied. We are aiming to conduct a retrospective observational study of all vv-ECMO patients treated at our ARDS centre.

Registry
clinicaltrials.gov
Start Date
June 1, 2022
End Date
August 1, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Goethe University
Responsible Party
Principal Investigator
Principal Investigator

Armin N. Flinspach

Physician

Goethe University

Eligibility Criteria

Inclusion Criteria

  • Patients treated with veno-venous extracorporeal membrane oxygenation (vv-ECMO) due to respiratory failure during acute respiratory distress syndrome (ARDS).

Exclusion Criteria

  • Patients treated with veno-arterial extracorporeal membrane oxygenation (va-ECMO)

Outcomes

Primary Outcomes

Survival of mechanical cardiovascular resuscitation

Time Frame: During the intensive care stay ( usually between 2 and 8 weeks)

Survival of mechanical cardiovascular resuscitation

Secondary Outcomes

  • Incidence of cardiovascular resuscitation i(During the observation period 2019-2022)
  • Complications of resuscitation treatments(During the intensive care stay ( usually between 2 and 8 weeks))

Study Sites (1)

Loading locations...

Similar Trials